Protocol to Permit the Acquisition of Circulating Tumor Material in Pancreatic Diseases

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-09-10

Study Completion Date

2035-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to collect blood samples to detect potential markers of pancreatic cancer in the blood and link these findings to medical and health information. Information from this study may help to provide insight into the detection of pancreas cancer in the blood before it can be found by other methods or provide a method of monitoring the status of pancreatic cancer throughout a treatment course. Another purpose of this study is to collect blood to create a biobank.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Collection of Circulating Biomarkers in Pancreatic Cancer

NCT05743049

Pancreas Cancer

RECRUITING

Feasibility of Obtaining and Characterizing Circulating Tumorigenic Cells in Patients With Pancreatic Adenocarcinoma

NCT01474564

Pancreatic Adenocarcinoma

COMPLETED

Pancreatic Adenocarcinoma Gene Environment Risk Study

NCT00912717

Pancreatic Cancer

RECRUITING

A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma

NCT03334708

Pancreatic Cancer Pancreatic Diseases Pancreatitis +1 more

RECRUITING

Collecting and Storing Samples of Blood From Patients With Pancreatic Cancer and Healthy Participants

NCT00898482

Pancreatic Cancer

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pancreatic Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. The subject must be a patient at the Hospital of the University of Pennsylvania

* The subject must be under evaluation and/or treatment for a pancreatic disease
* The subject must be under evaluation and/or treatment for a non-pancreatic disease. For example, patients undergoing routine colonoscopy within the clinical practice will be asked to consent to provide control samples.
2. The subject must be able to provide informed consent or have an acceptable surrogate capable of giving consent on the subject's behalf
3. The subject must be 18 years of age or older